Recent Updates
Recently added Catalysts
BBIO Positive Sentiment Score: 65/100

BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024

Tuesday, May 14, 2024 1 min read
Key Takeaway: BridgeBio Pharma, a biopharmaceutical company specializing in genetic diseases and cancers, has announced its participation in the Bank of America Merrill Lynch Global Healthcare Conference 2024. The presentation is scheduled for May 15 at 3:00 pm PT in Las Vegas, NV. Interested parties can access a live webcast of the event, with a replay available on BridgeBio's website for 90 days thereafter.

Market Sentiment Analysis

POSITIVE FACTORS

  • BridgeBio Pharma will present at a significant healthcare conference.
  • The event offers the opportunity for increased visibility and engagement.
  • Access to a live webcast allows broader participation from stakeholders.

Full Press Release Details

PALO ALTO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will present at the Bank of America Merrill Lynch Global Healthcare Conference 2024 in Las Vegas, NV on Wednesday, May 15 at 3:00 pm PT.
To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
contact@bridgebio.com

Frequently Asked Questions

When is BridgeBio presenting at the Bank of America Conference?

BridgeBio will present on May 15, 2024, at 3:00 pm PT.

How can I watch BridgeBio's presentation live?

The live webcast can be accessed on the Events & Presentations page of BridgeBio's website.

Where can I find the replay of the presentation?

The presentation replay will be available on BridgeBio's website for 90 days.

What is the focus of BridgeBio Pharma, Inc.?

BridgeBio specializes in genetic diseases and cancers.

Tags: BBIO Viatris Investor Conferences Healthcare BridgeBio BofA Merrill Lynch healthcare conference biopharmaceutical genetic diseases
Last updated: May 14, 2024